戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 d accumulation of activated microglia in the spongiform areas of the brain accompanied by an increase
2 nsfer ratios may be an in vivo surrogate for spongiform change and has potential utility as a therape
3  in mice with early prion infection reversed spongiform change and prevented clinical symptoms and ne
4 d increased interstitial space, vacuolation, spongiform change, and capillaries bent at amylin accumu
5 nation revealed neuronal loss, scant foci of spongiform change, and diffuse multicentric amyloid plaq
6 racterized by abundant PrP plaque formation, spongiform change, and gliosis.
7  deposition is accompanied by neuronal loss, spongiform change, astrogliosis, and conspicuous microgl
8  PrP(Sc), in the absence of neuronal loss or spongiform change, in the central nervous system corresp
9                              Cerebral cortex spongiform change, one of the classical pathological fea
10                                              Spongiform changes and intense PrP(Sc) staining were pre
11 h long incubation periods and characteristic spongiform changes associated with neuronal loss in the
12 p75(NTR)), and sortilin in the areas showing spongiform changes.
13 in PrP amyloid deposition, in the absence of spongiform changes.
14  We recently showed that hamster PrP induces spongiform degeneration and accumulates into highly aggr
15 of sick transgenic mice exhibited widespread spongiform degeneration and contained abnormal prion pro
16 l features that define prion strains include spongiform degeneration and deposition patterns of PrP(S
17  We show now that rabbit PrP does not induce spongiform degeneration and does not convert into scrapi
18 6Q), we provide evidence that glycans reduce spongiform degeneration and hinder plaque formation in p
19 al inactivation of Fig4 in neurons developed spongiform degeneration and the full spectrum of neurolo
20 ish the contributions of neurons and glia to spongiform degeneration in the Fig4 null mouse, we expre
21 ull mutation of Fig4 in the mouse results in spongiform degeneration of brain and peripheral ganglia,
22 to the signaling lipid PI(3,5)P(2) result in spongiform degeneration of mouse brain and are associate
23 ne that results in tremor, hypopigmentation, spongiform degeneration of the brain, and juvenile letha
24 cinity in the absence of clinical disease or spongiform degeneration of the brain.
25         Deficiency in this activity leads to spongiform degeneration of the white matter of the brain
26                                              Spongiform degeneration only occurs in the entorhinal co
27 markers and microgliosis but did not prevent spongiform degeneration or lethality.
28  inoculation of tissue from the case with no spongiform degeneration resulted in almost complete abse
29 llular and neurological phenotypes including spongiform degeneration, gliosis and juvenile lethality.
30 n the cerebellum affected by prions includes spongiform degeneration, neuronal loss, and gliosis.
31 ed the hallmarks of prion disease, including spongiform degeneration, pronounced astrogliosis, and de
32                                  The type of spongiform degeneration, the PrP immunostaining pattern,
33            To confirm the neuronal origin of spongiform degeneration, we generated a floxed allele of
34 urons is necessary and sufficient to prevent spongiform degeneration.
35                   Only one of the brains had spongiform degeneration.
36 of the prion protein, PrP-res, and displayed spongiform degeneration.
37                                Transmissible spongiform encephalitis (TSE) is a lethal illness with n
38 sease phenotype compared to the induction of spongiform encephalomyelitis with a longer latency, as s
39                              The progressive spongiform encephalomyelopathy caused by ts1, a neuropat
40      Since 2005, two cases of natural bovine spongiform encephalopathies (BSE) have been reported in
41    The risk of transmission of transmissible spongiform encephalopathies (TSE) between different spec
42                                Transmissible spongiform encephalopathies (TSE) can be contracted thro
43 ectious agent of the mammalian transmissible spongiform encephalopathies (TSE) has long been consider
44 t current diagnostic tests for transmissible spongiform encephalopathies (TSE) rely on the presence o
45                         In the transmissible spongiform encephalopathies (TSE), accumulation of the a
46 rotein that is responsible for transmissible spongiform encephalopathies (TSE).
47                The hallmark of transmissible spongiform encephalopathies (TSEs or prion diseases) is
48 se of the similarities between transmissible spongiform encephalopathies (TSEs) and other protein mis
49 pecies were not susceptible to transmissible spongiform encephalopathies (TSEs) and therefore represe
50                                Transmissible spongiform encephalopathies (TSEs) are a family of invar
51                                Transmissible spongiform encephalopathies (TSEs) are a family of invar
52                                Transmissible spongiform encephalopathies (TSEs) are a group of neurod
53                                Transmissible spongiform encephalopathies (TSEs) are associated with t
54                           Many transmissible spongiform encephalopathies (TSEs) are believed to be ca
55 zheimer's, Parkinson's and the transmissible spongiform encephalopathies (TSEs) are characterized by
56 ions responsible for mammalian transmissible spongiform encephalopathies (TSEs) are due primarily to
57                                Transmissible spongiform encephalopathies (TSEs) are fatal neurodegene
58                                Transmissible spongiform encephalopathies (TSEs) are fatal neurologica
59 ess studied, pregnancy-related transmissible spongiform encephalopathies (TSEs) have been implicated
60 duction reduced infectivity of transmissible spongiform encephalopathies (TSEs) in blood.
61                            The transmissible spongiform encephalopathies (TSEs) including scrapie hav
62                          Human transmissible spongiform encephalopathies (TSEs) or prion diseases are
63                                Transmissible spongiform encephalopathies (TSEs) or prion diseases are
64                                Transmissible spongiform encephalopathies (TSEs) or prion diseases are
65                                Transmissible spongiform encephalopathies (TSEs) represent a group of
66 s about the possible spread of transmissible spongiform encephalopathies (TSEs) via blood products.
67 ra of the eye for diagnosis of transmissible spongiform encephalopathies (TSEs) was examined.
68 lassical scrapie is one of the transmissible spongiform encephalopathies (TSEs), a group of fatal inf
69 on diseases, also known as the transmissible spongiform encephalopathies (TSEs), are a group of fatal
70             Prion diseases, or transmissible spongiform encephalopathies (TSEs), are a group of rare
71 ions, the infectious agents of transmissible spongiform encephalopathies (TSEs), have defied full cha
72                                Transmissible spongiform encephalopathies (TSEs), including scrapie in
73                                Transmissible spongiform encephalopathies (TSEs), or prion diseases, a
74     The agents responsible for transmissible spongiform encephalopathies (TSEs), or prion diseases, c
75 iginally formulated to explain transmissible spongiform encephalopathies (TSEs), the prion hypothesis
76                             In transmissible spongiform encephalopathies (TSEs), which are lethal neu
77 s associated with the onset of transmissible spongiform encephalopathies (TSEs).
78  the etiological agents of the transmissible spongiform encephalopathies (TSEs).
79 ectious agents responsible for transmissible spongiform encephalopathies (TSEs).
80 about the iatrogenic spread of transmissible spongiform encephalopathies (TSEs)/prion diseases throug
81  several patients with various transmissible spongiform encephalopathies (variant and sporadic Creutz
82                 Experiments on transmissible spongiform encephalopathies affecting rodents have led t
83                                Transmissible spongiform encephalopathies are a class of fatal neurode
84                                Transmissible spongiform encephalopathies are accompanied by the accum
85 nd systemic amyloidoses and prion-associated spongiform encephalopathies are acquired or inherited pr
86                                Transmissible spongiform encephalopathies are associated with conforma
87                                              Spongiform encephalopathies are believed to be transmitt
88              Prion diseases or transmissible spongiform encephalopathies are characterized histopatho
89                                Transmissible spongiform encephalopathies are fatal neurodegenerative
90                                Transmissible spongiform encephalopathies are lethal neurodegenerative
91                                Transmissible spongiform encephalopathies are neurodegenerative diseas
92 overy that devastating brain diseases called spongiform encephalopathies are transmissible to new hos
93 specimens for the diagnosis of transmissible spongiform encephalopathies has been described in sheep,
94 s prions that cause a group of transmissible spongiform encephalopathies in animals and humans.
95 associated with transmissible and hereditary spongiform encephalopathies in mammalian species.
96                 Propagation of transmissible spongiform encephalopathies is associated with the conve
97                 Propagation of transmissible spongiform encephalopathies is believed to involve the c
98 equired for the infectivity of transmissible spongiform encephalopathies is central to the debate abo
99 t blood in naturally occurring transmissible spongiform encephalopathies is not infectious has implod
100 the protein-only hypothesis of transmissible spongiform encephalopathies is the link between inherite
101 ation and neurotoxicity during transmissible spongiform encephalopathies is undisputed, the physiolog
102 prevalent manifestation of the transmissible spongiform encephalopathies or prion diseases affecting
103 , steps in the pathogenesis of transmissible spongiform encephalopathies or prion diseases.
104                Prion diseases (transmissible spongiform encephalopathies) are fatal neurodegenerative
105                                          For spongiform encephalopathies, a real prion can be transmi
106 ges in the prion protein cause transmissible spongiform encephalopathies, also referred to as prion d
107 se, type II diabetes mellitus, transmissible spongiform encephalopathies, and prion diseases.
108  Prion diseases, also known as transmissible spongiform encephalopathies, are fatal neurodegenerative
109 onic wasting disease and other transmissible spongiform encephalopathies, are misfolded proteins that
110 ectious agents responsible for transmissible spongiform encephalopathies, consist mainly of the misfo
111 ons, the etiological agents in transmissible spongiform encephalopathies, exhibit remarkable resistan
112 nto the causative agent of the transmissible spongiform encephalopathies, has previously been shown t
113 diagnosis and understanding of transmissible spongiform encephalopathies, including transmission mech
114 ntified as causative agents of transmissible spongiform encephalopathies, increasing evidence now sug
115                            The transmissible spongiform encephalopathies, more commonly known as the
116 e of its abnormal conformer in transmissible spongiform encephalopathies, normal PrP(C) may be implic
117                                Transmissible spongiform encephalopathies, or prion diseases, are caus
118 g approaches to the therapy of transmissible spongiform encephalopathies, or prion diseases, is beset
119          Prions, the agents of transmissible spongiform encephalopathies, require the expression of p
120  infected with prion diseases (transmissible spongiform encephalopathies, TSE).
121 ission of the prion disorders (transmissible spongiform encephalopathies, TSEs) are mediated by a mod
122 degenerative diseases known as transmissible spongiform encephalopathies, which affect humans, deer,
123 ectious agents responsible for transmissible spongiform encephalopathies, which appear to be composed
124 egenerative disorders known as transmissible spongiform encephalopathies.
125  is responsible for a range of transmissible spongiform encephalopathies.
126 generative diseases called the transmissible spongiform encephalopathies.
127 confer this high resistance to transmissible spongiform encephalopathies.
128 e devastating neurological diseases known as spongiform encephalopathies.
129 onformation is associated with transmissible spongiform encephalopathies.
130 he prevention of the spread of transmissible spongiform encephalopathies.
131 s of yet exists for any of the transmissible spongiform encephalopathies.
132 ng Alzheimer's disease and the transmissible spongiform encephalopathies.
133 gy resembling that observed in transmissible spongiform encephalopathies.
134 degenerative diseases known as transmissible spongiform encephalopathies.
135 are clinically associated with transmissible spongiform encephalopathies.
136  a prion that causes the fatal transmissible spongiform encephalopathies.
137 s to the infectious prion protein (PrPsc) in spongiform encephalopathies.
138 Two atypical BSE strains, bovine amyloidotic spongiform encephalopathy (BASE, also named BSE-L) and B
139 gh they were similarly exposed to the bovine spongiform encephalopathy (BSE) agent.
140 transmission efficiencies of vCJD and bovine spongiform encephalopathy (BSE) and an assessment of the
141       However, an association between bovine spongiform encephalopathy (BSE) and bovine PRNP exon 3 h
142 rodegenerative disorders that include bovine spongiform encephalopathy (BSE) and scrapie in animals a
143 l and neuropathological properties of bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-
144 , endemic sheep scrapie, and epidemic bovine spongiform encephalopathy (BSE) are caused by a related
145                  An experimental oral bovine spongiform encephalopathy (BSE) challenge study was perf
146                    However, since the bovine spongiform encephalopathy (BSE) crisis, their use has be
147 teins is strongly regulated since the bovine spongiform encephalopathy (BSE) crisis.
148 -Jakob disease, following on from the bovine spongiform encephalopathy (BSE) epidemic, led to concern
149 n transmission was reported after the bovine spongiform encephalopathy (BSE) epidemic, when >200 case
150 dily distinguished experimental sheep bovine spongiform encephalopathy (BSE) from classical scrapie.
151 n protein PrP(C), such as PrP(BSE) in bovine spongiform encephalopathy (BSE) in cattle and PrP(CJD) i
152  wasting disease (CWD) in cervids and bovine spongiform encephalopathy (BSE) in cattle are prion dise
153             Statutory surveillance of bovine spongiform encephalopathy (BSE) indicates that cattle ar
154                                    In bovine spongiform encephalopathy (BSE) infection, the polymorph
155                                       Bovine spongiform encephalopathy (BSE) is a transmissible spong
156                                       Bovine spongiform encephalopathy (BSE) is a TSE that occurs in
157                                       Bovine Spongiform Encephalopathy (BSE) is the only animal prion
158  samples in order to classify them as bovine spongiform encephalopathy (BSE) or non-BSE.
159  Creutzfeldt-Jakob disease (vCJD) and bovine spongiform encephalopathy (BSE) prions are two of the pr
160 ter the extensive dietary exposure to bovine spongiform encephalopathy (BSE) prions in the UK, has le
161                                       Bovine spongiform encephalopathy (BSE) prions were responsible
162 on protein (BoPrP) serially propagate bovine spongiform encephalopathy (BSE) prions without posing a
163  little about human susceptibility to bovine spongiform encephalopathy (BSE) prions, the causal agent
164 c mouse line, Tg(CerPrP)1536(+/-), to bovine spongiform encephalopathy (BSE) prions, which have the a
165 aused by dietary or other exposure to bovine spongiform encephalopathy (BSE) prions.
166 ause of the original case or cases of bovine spongiform encephalopathy (BSE) remains an enigma.
167             Foodborne transmission of bovine spongiform encephalopathy (BSE) to humans as variant Cre
168                However, its effect on bovine spongiform encephalopathy (BSE) transmission to goats is
169 ob disease (vCJD), experimental ovine bovine spongiform encephalopathy (BSE), and natural sheep scrap
170                                       Bovine spongiform encephalopathy (BSE), the prion disease in ca
171                                       Bovine spongiform encephalopathy (BSE)-associated prions were p
172 hat sheep and goats consumed the same bovine spongiform encephalopathy (BSE)-contaminated meat and bo
173 st certainly caused by consumption of bovine spongiform encephalopathy (BSE)-contaminated meat.
174 isease associated with infection with bovine spongiform encephalopathy (BSE)-like prions.
175 a zoonotic form of the cattle disease bovine spongiform encephalopathy (BSE).
176 iciency syndrome (AIDS), hepatitis C, bovine spongiform encephalopathy (BSE)/variant Creutzfeldt-Jako
177 e for neurodegenerative diseases like bovine spongiform encephalopathy (BSE; "mad cow" disease) and C
178 eases of cattle include the classical bovine spongiform encephalopathy (C-BSE) and the atypical H-typ
179                             Classical bovine spongiform encephalopathy (c-BSE) is the only animal pri
180 c wasting disease (CWD) and classical bovine spongiform encephalopathy (cBSE) prions.
181  have been shown to be susceptible to feline spongiform encephalopathy (FSE), almost certainly caused
182 sceptible to the prion causing L-type bovine spongiform encephalopathy (L-BSE), although RQ171 sheep
183 affected by C-BSE and atypical L-type bovine spongiform encephalopathy (L-type BSE or L-BSE) with the
184 mals (n = 80) and 71% of animals with bovine spongiform encephalopathy (n = 7).
185 g disease (CWD) is an emerging transmissible spongiform encephalopathy (prion disease) of North Ameri
186 ep scrapie is the prototypical transmissible spongiform encephalopathy (prion disease), which has a f
187 chronic waste disease (PrP(CWD)), and bovine spongiform encephalopathy (PrP(BSE)) in lab-scale compos
188 ible to humans, as has been shown for bovine spongiform encephalopathy (the prion disease of cattle),
189 form encephalopathy (BSE) is a transmissible spongiform encephalopathy (TSE) (or prion disease) that
190          This is evidence that transmissible spongiform encephalopathy (TSE) agent properties alone,
191  Following oral exposure, some transmissible spongiform encephalopathy (TSE) agents accumulate first
192               As with viruses, transmissible spongiform encephalopathy (TSE) agents can adapt to new
193  of many peripherally acquired transmissible spongiform encephalopathy (TSE) agents is less efficient
194 presented here, using the same transmissible spongiform encephalopathy (TSE) animal model, our aim wa
195                                Transmissible spongiform encephalopathy (TSE) can be induced in animal
196 protease-resistant PrP without transmissible spongiform encephalopathy (TSE) clinical signs or notabl
197                   Diagnosis of transmissible spongiform encephalopathy (TSE) disease in humans and ru
198                 Agents causing transmissible spongiform encephalopathy (TSE) diseases are resistant t
199  infectious agents (prions) of transmissible spongiform encephalopathy (TSE) diseases including chron
200 l infectious agents that cause transmissible spongiform encephalopathy (TSE) diseases, or prion disea
201 od transfusion exists for many transmissible spongiform encephalopathy (TSE) diseases.
202 ectious agents responsible for transmissible spongiform encephalopathy (TSE) diseases.
203 sly undetected sporadic bovine transmissible spongiform encephalopathy (TSE) have long been considere
204 dvantageous model for studying transmissible spongiform encephalopathy (TSE) infection.
205                                Transmissible spongiform encephalopathy (TSE) infectivity naturally sp
206 nic wasting disease (CWD) is a transmissible spongiform encephalopathy (TSE) of cervids now detected
207                 Scrapie is the transmissible spongiform encephalopathy (TSE) of sheep and goats, and
208 the iatrogenic transmission of transmissible spongiform encephalopathy (TSE) or prion disease has bec
209                  The viral and transmissible spongiform encephalopathy (TSE) safety of therapeutics o
210 eared to be dependent upon the transmissible spongiform encephalopathy (TSE) strain, allowing discrim
211                      Different transmissible spongiform encephalopathy (TSE)-associated forms of prio
212  discriminatory testing of all transmissible spongiform encephalopathy (TSE)-positive small ruminant
213 are infected with prions from cattle (bovine spongiform encephalopathy [BSE]), both PrP variants occu
214 line CWD (fCWD) and feline BSE (i.e., feline spongiform encephalopathy [FSE]).
215 e (CWD) is a universally fatal transmissible spongiform encephalopathy affecting cervids, and natural
216 essing cells appear to support transmissible spongiform encephalopathy agent replication.
217           The process by which transmissible spongiform encephalopathy agents, or prions, infect cell
218 degenerative diseases, such as transmissible spongiform encephalopathy and Alzheimer disease.
219 roinvasion in many prion diseases, in bovine spongiform encephalopathy and atypical cases of sheep sc
220 al host systems, including strains of bovine spongiform encephalopathy and chronic wasting disease.
221 nfluence the susceptibility to transmissible spongiform encephalopathy and determine the characterist
222 T treatment also inhibits the development of spongiform encephalopathy and gliosis in the central ner
223 ldt-Jakob disease (CJD) in humans and bovine spongiform encephalopathy and scrapie in animals.
224 ecific, and early diagnosis of transmissible spongiform encephalopathy and to further understand the
225  wild-type mice and was also found in bovine spongiform encephalopathy cattle brain, indicating that
226                 Human transmission of bovine spongiform encephalopathy causes the fatal neurodegenera
227 n to replicate many aspects of transmissible spongiform encephalopathy disease to investigate the cel
228              Prion diseases or transmissible spongiform encephalopathy diseases are typically charact
229 kob disease in humans and scrapie and bovine spongiform encephalopathy in animals.
230 sease in humans, scrapie in sheep and bovine spongiform encephalopathy in cattle.
231 n, we show that prions causing transmissible spongiform encephalopathy in wild-type hamsters can be g
232 als in feedstuffs in order to prevent Bovine Spongiform Encephalopathy infection and diffusion, howev
233  significant removal of rodent transmissible spongiform encephalopathy infections by filtration of re
234 sarily be a reliable marker of transmissible spongiform encephalopathy infectivity.
235  hypothesis that human infection with bovine spongiform encephalopathy occurred in Saudi Arabia.
236 ronic wasting disease (CWD), a transmissible spongiform encephalopathy of cervids, was first document
237 ronic wasting disease (CWD), a transmissible spongiform encephalopathy of cervids, was first document
238 ronic wasting disease (CWD), a transmissible spongiform encephalopathy of deer, elk, and moose, is th
239 d factor for susceptibility to transmissible spongiform encephalopathy or prion diseases.
240 ry response may play a role in transmissible spongiform encephalopathy pathogenesis.
241                     Just as spread of bovine spongiform encephalopathy prion variant is less impaired
242                   We demonstrate that bovine spongiform encephalopathy prions maintain their transspe
243 ion strain resulting from exposure to bovine spongiform encephalopathy prions to which the Fore were
244  in those with primary infection with bovine spongiform encephalopathy prions.
245 sive to infection with natural transmissible spongiform encephalopathy strains.
246 ged into at least two distinct transmissible spongiform encephalopathy strains.
247     Chronic wasting disease (CWD) is a fatal spongiform encephalopathy that is efficiently transmitte
248 imental challenge and the outbreak of bovine spongiform encephalopathy that occurred in the late 1980
249 l as the interspecies transmission of bovine spongiform encephalopathy to humans in the form of varia
250 linical signs, neuropathology (transmissible spongiform encephalopathy vacuolation and prion protein
251 ronic wasting disease of cervids, and bovine spongiform encephalopathy) all seem to be laterally tran
252 on with a single strain of the agent (bovine spongiform encephalopathy).
253 raperitoneal, or oral); all groups developed spongiform encephalopathy, although the oral route requi
254 g PrP-101L with neurological disease, severe spongiform encephalopathy, and formation of proteinase K
255  were fed brain of (eleven) cows with bovine spongiform encephalopathy, and some were euthanized befo
256   Some animal prion diseases, such as bovine spongiform encephalopathy, can infect humans; however, h
257  21 overlap with QTLs associated with Bovine spongiform encephalopathy, clinical mastitis or somatic
258 risks posed by prion zoonoses such as bovine spongiform encephalopathy, has focused much attention on
259                                Transmissible spongiform encephalopathy-associated forms from mouse an
260 an form of a prion disease of cattle, bovine spongiform encephalopathy-have been reported from 12 cou
261 ritical goal of discriminating transmissible spongiform encephalopathy-infected from healthy uninfect
262 stant core identical to that found in bovine spongiform encephalopathy-specific scrapie-associated pr
263 evalence in the United Kingdom with a bovine spongiform encephalopathy-unexposed population.
264 shown to develop a spontaneous transmissible spongiform encephalopathy.
265 chronic wasting disease, scrapie, and bovine spongiform encephalopathy.
266 disease, a naturally occurring transmissible spongiform encephalopathy.
267 st system to study this cervid transmissible spongiform encephalopathy.
268 nts including Alzheimer's disease and bovine spongiform encephalopathy.
269 cluding Creutzfeldt-Jakob disease and bovine spongiform encephalopathy.
270 otes PrP amyloidogenesis in the absence of a spongiform encephalopathy.
271  transgenic mice (Tg PrP101LL), resulting in spongiform encephalopathy.
272 om sheep with scrapie and cattle with bovine spongiform encephalopathy.
273 mum global risk for human exposure to bovine spongiform encephalopathy.
274 degenerative diseases known as transmissible spongiform encephalopathy.
275 evention of human dietary exposure to bovine spongiform encephalopathy.
276 nisms and/or at the onset of a transmissible spongiform encephalopathy.
277 herited prion disease; sheep scrapie; bovine spongiform encephalopathy; and chronic wasting disease.
278 disorder originating from exposure to bovine-spongiform-encephalopathy-like prions.
279 ibility and phenotype of human transmissible spongiform encyphalopathies, but the molecular mechanism
280 of PrP(Sc) deposits within the brain and the spongiform lesions they induce.
281 on of the Nrf2 gene in mice caused vacuolar (spongiform) leukoencephalopathy with widespread astrogli
282 s) are capable of inducing fatal progressive spongiform motor neuron disease in mice that is largely
283  murine leukemia virus (MLV) can cause acute spongiform neurodegeneration analogous to that induced b
284 ll defined even though a loss of neurons and spongiform neurodegeneration has been reported to accomp
285 sE and Moloney MLV-ts1 cause noninflammatory spongiform neurodegeneration in mice, manifested clinica
286 ons of FIG4 result in juvenile lethality and spongiform neurodegeneration in the mouse, and are respo
287 MLVs) can induce progressive noninflammatory spongiform neurodegeneration similar to that caused by p
288 y ataxia and paralysis and the appearance of spongiform neurodegeneration throughout the brain stem a
289 E3 ubiquitin-protein ligase Mahogunin causes spongiform neurodegeneration, a recessively transmitted
290           These pathological changes include spongiform neurodegeneration, astrogliosis, thymic atrop
291 nfection and before any marked appearance of spongiform neurodegeneration, we detected vessel leakage
292 cytosolic ubiquitin ligase whose loss causes spongiform neurodegeneration.
293 n dysregulation of endosomal trafficking and spongiform neurodegeneration.
294             Some murine retroviruses cause a spongiform neurodegenerative disease exhibiting patholog
295 oup of ecotropic murine retroviruses cause a spongiform neurodegenerative disease manifested by tremo
296  strong support for the hypothesis that this spongiform neurodegenerative disease represents a virus-
297 , no malignancies were detected in cystic or spongiform nodules (both, n = 11, 2.8%; 95% CI: 1.4%, 5.
298 logical function accompany early hippocampal spongiform pathology.
299 blocks neuronal cell loss and reverses early spongiform pathology.
300 spartic acid, elevates brain NAA and causes "spongiform" vacuolation of superficial brain white matte

 
Page Top